Scribe Therapeutics Inc.'s (NASDAQ:SCTX) Quiet Period Will End on September 2nd
MarketBeat
Scribe Therapeutics' (NASDAQ:SCTX - Get Free Report) quiet period will end on Wednesday, September 2nd. Scribe Therapeutics had issued 8,580,000 shares in its public offering on July 24th. The total size of the offering was $128,700,000 based on an initial share price of $15.00. During Scribe Therapeutics' quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
NASDAQ:SCTX